Short-term effects of tamoxifen, medroxyprogesterone acetate, and their combination on receptor kinetics and 17�-hydroxysteroid dehydrogenase in human endometrium

Obstetrics and Gynecology

Volumn 66, Issue 5, 1985, Pages 695-700

  Neumannov�, M ^a   Kauppila, A ^a   Kivinen, S ^a   Vihko, R ^a  

^a UNIVERSITY OF OULU   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

16ALPHA ETHYL 21 HYDROXY 19 NORPREGN 4 ENE 3,20 DIONE H 3; ENZYME; ESTROGEN RECEPTOR; MEDROXYPROGESTERONE; MEDROXYPROGESTERONE ACETATE; PROGESTERONE RECEPTOR; RADIOISOTOPE; TAMOXIFEN; TESTOSTERONE 17BETA DEHYDROGENASE; UNCLASSIFIED DRUG;

16ALPHA ETHYL 21 HYDROXY 19 NORPREGN 4 ENE 3,20 DIONE H 3; CANCER COMBINATION CHEMOTHERAPY; CYTOLOGY; CYTOSOL; DRUG MECHANISM; DRUG MIXTURE; DRUG RECEPTOR BINDING; ENDOMETRIUM; ESTRADIOL H 3; ESTRONE C 14; FEMALE GENITAL SYSTEM; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; NORMAL HUMAN; PHARMACOKINETICS; PRIORITY JOURNAL; THERAPY;

17-HYDROXYSTEROID DEHYDROGENASES; ADULT; CYTOSOL; DRUG INTERACTIONS; ENDOMETRIUM; FEMALE; HUMAN; KINETICS; MEDROXYPROGESTERONE; MEDROXYPROGESTERONE 17-ACETATE; MENSTRUATION; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; STIMULATION, CHEMICAL; SUPPORT, NON-U.S. GOV'T; TAMOXIFEN; TIME FACTORS;

EID: 0022356329     PISSN: 00297844     EISSN: 1873233X     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Jänne O, Kauppila A, Kontula K, et al: Female sex steroid receptors in normal, hyperplastic and carcinomatous endometrium. The relationship to serum steroid hormones and gonadotropins and changes during medroxyprogesterone acetate administration. Int J Cancer 24:545, 1979
2. Martin PM, Rolland PH, Gammerre M, et al: Estradiol and progesterone receptors in normal and neoplastic endometrium: Correlations between receptors, histopathological examinations and clinical responses under progestin therapy. Int J Cancer 23:321, 1979
3. Levy C, Robel P, Wolff JP, et al: Hormone receptors as indicators of the biological properties of neoplastic tissues, Advances in Medical Oncology, Research and Education. Vol 5, Basis for Cancer Therapy 1. Edited by BW Fox. Oxford, Pergamon Press, 1979, p 213
4. Namer M, Lalanne C, Baulieu E-E: Increase of progesterone receptor by tamoxifen as a hormonal challenge test in breast cancer. Cancer Res 40:1750, 1980
5. Mortel R, Levy C, Wolff J-P, et al: Female sex steroid receptors in postmenopausal endometrial carcinoma and biochemical response to an antiestrogen. Cancer Res 41:1140, 1981
6. Swenerton KD: Treatment of advanced endometrial adenocarcinoma with tamoxifen. Cancer Treat Rep 64:805, 1980
7. Swenerton KD: Endometrial adenocarcinoma, Clinics in Oncology. Vol 1, Hormone Therapy. Edited by BJA Furr. London-Philadelphia-Toronto, W. B. Saunders Company Ltd, 1982, p 215
8. Hammond GL, Viinikka L, Vihko R: Automation of radioimmunoassays for some sex steroids with use of both iodinated and tritiated ligands. Clin Chem 23:1250, 1977
9. Kokko E, Jänne O, Kauppila A, et al: Effects of tamoxifen, medroxyprogesterone acetate, and their combination on human endometrial estrogen and progestin receptor concentrations, 17β-hydroxysteroid dehydrogenase activity, and serum hormone concentrations. Am J Obstet Gynecol 143:382, 1982
10. Lowry OH, Rosebrough NJ, Farr AL, et al: Protein measurement with the Folin phenol reagents. J Biol Chem 193:265, 1951
11. Burton K: A study of the conditions and mechanism of the diphenylamine relation for the colorimetric estimation of deoxyribonucleic acid. Biochem J 62:315, 1956
12. Bayard F, Damilano S, Robel P, et al: Cytoplasmic and nuclear estradiol and progesterone receptors in human endometrium. J Clin Endocrinol Metab 46:635, 1978
13. Jänne O, Kontula K, Vihko R: Progestin receptors in human tissues: Concentrations and binding kinetics. J Steroid Biochem 7:1061, 1976
14. Scatchard G: The attraction of proteins for small molecules and ions. Ann NY Acad Sci 51:660, 1949
15. Leinonen P: Estrone and estradiol concentrations in the testis and spermatic and peripheral venous blood of elderly men: The influence of estrogen treatment. J Steroid Biochem 13:737, 1980
16. Wallenstein S, Zucker CL, Fleiss JL: Some statistical methods useful in circulation research. Circ Res 47:1, 1980
17. Kauppila A, Isotalo H, Kivinen S, et al: Short-term effects of danazol and medroxyprogesterone acetate on cytosol and nuclear estrogen and progestin receptors, 17/3-hydroxy steroid dehydrogenase activity, histopathology, and ultrastructure of human endometrial adenocarcinoma. Int J Cancer 35:157, 1985
18. Jänne O, Kontula K, Luukkainen T, et al: Oestrogen-induced progesterone receptor in human uterus. J Steroid Biochem 6:501, 1975
19. Tseng L, Gusberg SB, Gurpide E: Estradiol receptor and 17/3-dehydrogenase in normal and abnormal human endometrium. Ann NY Acad Sci 286:190, 1977
20. King RJB, Whitehead Ml, Campbell S, et al: Effect of estrogen and progestin treatments on endometria from postmenopausal women. Cancer Res 39:1094, 1979
21. Kreitman B, Bugat R, Bayard F: Estrogen and progestin regulation of the progesterone receptor concentration in human endometrium. J Clin Endocrinol Metab 49:926, 1979
22. Eckert RL, Katzenellenbogen BS: Human endometrial cells in primary tissue culture: Modulation of the progesterone receptor level bv natural and synthetic estrogens in vitro. J Clin Endocrinol Metab 52:699, 1981
23. Whitehead MI, Townsend PT, Pryse-Davies J, et al: Effects of estrogens and progestins on the biochemistry and morphology of the postmenopausal endometrium. N Engl J Med 305:1599, 1981
24. Tseng L, Gurpide E: Induction of human estradiol dehydrogenase by progestins. Endocrinology 97:825, 1974
25. Gurpide E: Hormone receptors in endometrial cancer. Cancer 48:641, 1981
26. Waseda N, Kato Y, Imura H, et al: Effects of tamoxifen on estrogen and progesterone receptors in human breast cancer. Cancer Res 41:1984, 1981
27. Isomaa V, Isotalo H, Orava M, et al: Regulation of cytosol and nuclear progesterone receptors in rabbit uterus by estrogen, antiestrogen and progesterone administration. Biochim Biophvs Acta 585:24, 1979
28. Isomaa V: In vitro binding to and in vivo effect on the cytosol and nuclear progesterone receptors of various progestins, and their relation to synthesis of uteroglobin in rabbit uterus. Biochim Biophys Acta 675:9, 1981
29. McGuire WL: New strategies for investigating antiestrogen action in breast cancer. Cancer Res 42:3420S, 1982
30. Neulen J, Beato M, Beier HM: Cytosol and nuclear progesterone-receptor concentrations in the rabbit endometrium during early pseudopregnancy under different treatments with estradiol and progesterone. Mol Cell Endocrinol 25:183, 1982
31. Kokko E, Jänne O, Kauppila A, et al: Cyclic clomiphene citrate treatment lowers cytosol estrogen and progestin receptor concentrations in the endometrium of postmenopausal women on estrogen replacement therapy. J Clin Endocrinol Metab 52:345, 1981
32. Bonte J, lde P, Billiet G, et al: Tamoxifen as possible chemotherapeutic agent in endometrial adenocarcinoma. Gynecol Oncol 11:1490, 1981
33. Kauppila A, Vihko R: Endometrial carcinoma insensitive to progestin and cytotoxic chemotherapy may respond to tamoxifen. Acta Obstet Gynecol Scand 60:589, 1981
34. Quinn MA, Campbell JJ, Murray R, et al: Tamoxifen and amino-glutethimide in the management of patients with advanced endometrial carcinoma not responsive to medroxyprogesterone. Aust NZ J Obstet Gynaecol 21:226, 1981